BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24732594)

  • 21. Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy.
    Cutrona G; Matis S; Colombo M; Massucco C; Baio G; Valdora F; Emionite L; Fabris S; Recchia AG; Gentile M; Neumaier CE; Reverberi D; Massara R; Boccardo S; Basso L; Salvi S; Rosa F; Cilli M; Zupo S; Truini M; Tassone P; Calabrese M; Negrini M; Neri A; Morabito F; Fais F; Ferrarini M
    Leukemia; 2017 Sep; 31(9):1894-1904. PubMed ID: 28053325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of multiple cell clones over a 29-year period of a CLL patient.
    Zhao Z; Goldin L; Liu S; Wu L; Zhou W; Lou H; Yu Q; Tsang SX; Jiang M; Li F; McMaster M; Li Y; Lin X; Wang Z; Xu L; Marti G; Li G; Wu K; Yeager M; Yang H; Xu X; Chanock SJ; Li B; Hou Y; Caporaso N; Dean M
    Nat Commun; 2016 Dec; 7():13765. PubMed ID: 27982015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel mechanisms of regulation of miRNAs in CLL.
    Balatti V; Acunzo M; Pekarky Y; Croce CM
    Trends Cancer; 2016 Mar; 2(3):134-143. PubMed ID: 27213184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells.
    Mongini PK; Gupta R; Boyle E; Nieto J; Lee H; Stein J; Bandovic J; Stankovic T; Barrientos J; Kolitz JE; Allen SL; Rai K; Chu CC; Chiorazzi N
    J Immunol; 2015 Aug; 195(3):901-23. PubMed ID: 26136429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-15a and miR-16 induce autophagy and enhance chemosensitivity of Camptothecin.
    Huang N; Wu J; Qiu W; Lyu Q; He J; Xie W; Xu N; Zhang Y
    Cancer Biol Ther; 2015; 16(6):941-8. PubMed ID: 25945419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of microRNA in chronic lymphocytic leukemia onset and progression.
    Balatti V; Pekarky Y; Croce CM
    J Hematol Oncol; 2015 Feb; 8():12. PubMed ID: 25886051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic lymphocytic leukemia: molecular genetics and animal models.
    Pekarsky Y; Calin GA; Aqeilan R
    Curr Top Microbiol Immunol; 2005; 294():51-70. PubMed ID: 16323427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia.
    Veronese A; Pepe F; Chiacchia J; Pagotto S; Lanuti P; Veschi S; Di Marco M; D'Argenio A; Innocenti I; Vannata B; Autore F; Marchisio M; Wernicke D; Verginelli F; Leone G; Rassenti LZ; Kipps TJ; Mariani-Costantini R; Laurenti L; Croce CM; Visone R
    Leukemia; 2015 Jan; 29(1):86-95. PubMed ID: 24732594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemia.
    Kasar S; Underbayev C; Yuan Y; Hanlon M; Aly S; Khan H; Chang V; Batish M; Gavrilova T; Badiane F; Degheidy H; Marti G; Raveche E
    Oncogene; 2014 Jun; 33(25):3307-15. PubMed ID: 23995789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia.
    Fabbri M; Bottoni A; Shimizu M; Spizzo R; Nicoloso MS; Rossi S; Barbarotto E; Cimmino A; Adair B; Wojcik SE; Valeri N; Calore F; Sampath D; Fanini F; Vannini I; Musuraca G; Dell'Aquila M; Alder H; Davuluri RV; Rassenti LZ; Negrini M; Nakamura T; Amadori D; Kay NE; Rai KR; Keating MJ; Kipps TJ; Calin GA; Croce CM
    JAMA; 2011 Jan; 305(1):59-67. PubMed ID: 21205967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.
    Klein U; Lia M; Crespo M; Siegel R; Shen Q; Mo T; Ambesi-Impiombato A; Califano A; Migliazza A; Bhagat G; Dalla-Favera R
    Cancer Cell; 2010 Jan; 17(1):28-40. PubMed ID: 20060366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
    Braga TV; Evangelista FCG; Gomes LC; Araújo SSDS; Carvalho MDG; Sabino AP
    Biomed Pharmacother; 2017 Aug; 92():864-869. PubMed ID: 28599250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1.
    Lerner M; Harada M; Lovén J; Castro J; Davis Z; Oscier D; Henriksson M; Sangfelt O; Grandér D; Corcoran MM
    Exp Cell Res; 2009 Oct; 315(17):2941-52. PubMed ID: 19591824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kaposi's sarcoma-associated herpesvirus microRNA single-nucleotide polymorphisms identified in clinical samples can affect microRNA processing, level of expression, and silencing activity.
    Han SJ; Marshall V; Barsov E; Quiñones O; Ray A; Labo N; Trivett M; Ott D; Renne R; Whitby D
    J Virol; 2013 Nov; 87(22):12237-48. PubMed ID: 24006441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.
    Landau DA; Carter SL; Stojanov P; McKenna A; Stevenson K; Lawrence MS; Sougnez C; Stewart C; Sivachenko A; Wang L; Wan Y; Zhang W; Shukla SA; Vartanov A; Fernandes SM; Saksena G; Cibulskis K; Tesar B; Gabriel S; Hacohen N; Meyerson M; Lander ES; Neuberg D; Brown JR; Getz G; Wu CJ
    Cell; 2013 Feb; 152(4):714-26. PubMed ID: 23415222
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.